Compare CSCO & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSCO | PFE |
|---|---|---|
| Founded | 1984 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 335.1B | 155.2B |
| IPO Year | 2002 | 2013 |
| Metric | CSCO | PFE |
|---|---|---|
| Price | $78.14 | $26.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 12 |
| Target Price | ★ $88.00 | $27.83 |
| AVG Volume (30 Days) | 20.7M | ★ 31.5M |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | 2.16% | ★ 6.40% |
| EPS Growth | ★ 0.39 | N/A |
| EPS | ★ 1.51 | 1.36 |
| Revenue | $49,330,000,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $10.85 | N/A |
| Revenue Next Year | $5.76 | N/A |
| P/E Ratio | $51.44 | ★ $19.76 |
| Revenue Growth | ★ 2.76 | N/A |
| 52 Week Low | $52.11 | $20.92 |
| 52 Week High | $88.19 | $27.94 |
| Indicator | CSCO | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 48.58 | 47.27 |
| Support Level | $73.08 | $26.29 |
| Resistance Level | $80.30 | $26.74 |
| Average True Range (ATR) | 1.60 | 0.53 |
| MACD | -0.19 | -0.08 |
| Stochastic Oscillator | 50.12 | 28.87 |
Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff-25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.